Injective price outlook: Upward momentum remains despite overbought signals

Injective price outlook: Upward momentum remains despite overbought signals
Injective gains 7% today to $8.08

Injective (INJ) is trading at $8.08, up 7% on the day. The price is holding well above its short- and medium-term moving averages, reflecting strong near-term momentum.

INJ price prediction
24H 0.29%
$7.01
48H -1.29%
$6.9
7D -16.31%
$5.85
1M -0.72%
$6.94
3M -62.95%
$2.59
6M -76.54%
$1.64
12M 30.33%
$9.11
Current price: $6.99 0.2 3.01%
Real-time Data 22:49
Daily range 6.56 Arrow from to Icon 7.25
Weekly range 6.66 Arrow from to Icon 8.44
Loading...

Highlights

  • INJ/USD maintains a bullish structure across hourly and daily timeframes with strong upward momentum.
  • Key technical indicators indicate overbought conditions and possible short-term pullback risk despite ongoing buyer control.
  • The projected 1 to 2 day range is $7.64 to $8.53 with a 71% probability of further upside.

Upside momentum accelerates as overbought signals emerge

On the technical front, INJ/USD remains firmly above its MA-20 and MA-50 levels on the hourly chart, while the daily chart shows price far above the MA-200. The Ichimoku Kijun currently sits at $7.75 as immediate support. MACD and ADX are both presenting a buy setup, and RSI reads at 65.71, reflecting strong upward momentum. Stoch RSI and CCI are indicating overbought conditions, suggesting that while the rally is robust, some near-term pullback risk is present. Bull/Bear Power confirms buyer dominance, and the Awesome Oscillator aligns with the prevailing upward trend.

Injective asset chart
Injective price dynamics. Source: TradingView.

Upside bias holds as consolidation and breakout risks persist

For the next one to two trading days, the anticipated range for INJ/USD is $7.64 to $8.53, based on current volatility. The probability favors further gains at 71%, with downside risks at 29%. The baseline scenario points to consolidation within this band, but a breakout above resistance could open room for additional upside, while a drop below $7.75 would threaten a deeper pullback.

Viktoras Karapetjanc, expert at Traders Union, sees further upside potential in Injective (INJ) given the strong price action and bullish technical setup. He notes the clear dominance of buyers, as well as robust momentum across several key indicators. However, Karapetjanc acknowledges the chance of short-term pullbacks due to overbought conditions, but maintains a constructive outlook. "With technicals favoring bulls and a firm support base, I expect INJ to attempt further gains toward the top of the expected range in the coming days."

Previously it was reported that Injective faced sustained downside risk as technical signals and elevated exchange deposits fueled bearish momentum. The current technical setup marks a notable shift, with momentum now favoring buyers and immediate attention on the $7.75 support as the key level that could determine the durability of the recent rally.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.